跳至主要内容
临床试验/IRCT20220416054548N1
IRCT20220416054548N1招募中2 期

Determining the association of response rate to Intravitreal injection of bevacizumab and macular vessel density in patients with diabetic macular edema using optical coherence tomography angiography (OCT-A) in outpatients referred to Feyz Hospital

Esfahan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Having type 1 or 2 diabetes
  • Central macular edema based on Heidelberg's clinical examination and OCT in one or both eyes (at least 305 µm in women and 320 µm in men)
  • Best modified view less than or equal to 10/7
  • No history of laser in the patient's eye
  • Moderate to severe non-proliferative diabetic retinopathy with diabetic macular edema
  • Transparent media to the extent that it does not interfere with the quality of images and their analysis (SSI: signal strength index: 37-40)

排除标准

  • History of retinal vascular obstructive diseases
  • History of intraocular injection in the last 6 months
  • History of intraocular and retinal laser in the affected eye in the last 12 months
  • Decreased vision following any ocular pathology other than diabetic retinopathy
  • High Myopia (= -8)
  • History of eye surgery in the last 6 months
  • Uncontrolled glaucoma (IOP = 30 mmHg despite maximal treatment)
  • Uncontrolled diabetes
  • Uncontrolled blood pressure (SBP =180 mmHg or DBP =100 mmHg
  • Connective tissue diseases

研究者

相似试验